Skip to main content

Advertisement

Table 5 Total direct and indirect out-of-pocket costs accrued by patients with advanced NSCLC and their caregivers by disease stage

From: Cost burden associated with advanced non-small cell lung cancer in Europe and influence of disease stage

  Patients Caregivers
Mean annual cost outcome Stage IIIB (n = 119) Stage IV (n = 911) Stage IIIB (n = 30) Stage IV (n = 397)
Total direct and indirect out-of-pocket costs (unadjusted) n = 51 €3528 n = 471 €5925 n = 19 €2232 n = 185 €4319
Financial support received from government n = 110 €737 n = 879 €2282 n = 29 €663 n = 357 €726
Total direct and indirect out-of-pocket costs (adjusteda) n = 50 €2548 n = 468 €2654 n = 18 €2241 n = 176 €3603
  1. NSCLC non-small cell lung cancer
  2. aAdjusted for financial support provided by the respective governments